Substance list · United Kingdom
GB mandatory classification and labelling list (GB MCL list, GB CLP Article 38A), file of 19 May 2026 (page 7)
Labelling: mandatory hazard classification, labelling, specific concentration limits, M factors and ATEs.
- When it applies
- Every substance on the list and every mixture containing it, placed on the GB market
- Entries
- 4429
- Version date
- 2026-05-19
- Guide
- United Kingdom
Entries 3001 to 3500 of 4429
500 rows
| Substance | English name | CAS | EC | Type | Category | Threshold | Conditions |
|---|---|---|---|---|---|---|---|
| pyridine | pyridine | 110-86-1 | 203-809-9 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | * | Hazard statement codes: H225; H332; H312; H302. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H332; H312; H302 |
| 1,2,3,4-tetranitrocarbazole | 1,2,3,4-tetranitrocarbazole | 6202-15-9 | substance | Expl. 1.1; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H201; H332; H312; H302. Labelling pictogram and signal word: GHS01; GHS07; Dgr. Labelling hazard statements: H201; H332; H312; H302 | ||
| crimidine (ISO); 2-chloro-6-methylpyrimidin-4-yldimethylamine | crimidine (ISO); 2-chloro-6-methylpyrimidin-4-yldimethylamine | 535-89-7 | 208-622-6 | substance | Acute Tox. 2 * | Hazard statement codes: H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H300 | |
| desmetryne (ISO); 6-isopropylamino-2-methylamino- 4-methylthio-1,3,5-triazine | desmetryne (ISO); 6-isopropylamino-2-methylamino- 4-methylthio-1,3,5-triazine | 1014-69-3 | 213-800-1 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H410 | |
| dazomet (ISO); tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione | dazomet (ISO); tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione | 533-74-4 | 208-576-7 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H410 | |
| 2,4,6-trichloro-1,3,5-triazine; cyanuric chloride | 2,4,6-trichloro-1,3,5-triazine; cyanuric chloride | 108-77-0 | 203-614-9 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H330; H302; H314; H317. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H330; H302; H314; H317. Supplementary hazard statements: EUH014 |
| ametryn (ISO); N-ethyl-N'-isopropyl-6-(methylthio)- 1,3,5-triazine-2,4-diamine | ametryn (ISO); N-ethyl-N'-isopropyl-6-(methylthio)- 1,3,5-triazine-2,4-diamine | 834-12-8 | 212-634-7 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 |
| amitrole (ISO); 1,2,4-triazol-3-ylamine | amitrole (ISO); 1,2,4-triazol-3-ylamine | 61-82-5 | 200-521-5 | substance | Repr. 2; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H361d ***; H373 **; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d ***; H373 **; H411 | |
| bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide | bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide | 25057-89-0 | 246-585-8 | substance | Repr. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 | Oral: ATE = 1600 mg/kg bw | Hazard statement codes: H361d; H302; H319; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361d; H302; H319; H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| cyanazine (ISO); 2-(4-chloro-6-ethylamino-1,3,5-triazine- 2-ylamino)-2-methylpropionitrile | cyanazine (ISO); 2-(4-chloro-6-ethylamino-1,3,5-triazine- 2-ylamino)-2-methylpropionitrile | 21725-46-2 | 244-544-9 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| ethoxyquin(ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline | ethoxyquin(ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline | 91-53-2 | 202-075-7 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate | fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate | 14255-88-0 | 238-134-9 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H410 | |
| fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole | fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole | 3878-19-1 | 223-404-0 | substance | Carc. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | Hazard statement codes: H351; H302; H373 (heart); H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H351; H302; H373 (heart); H317; H410 |
| bis (8-hydroxyquinolinium) sulphate | bis (8-hydroxyquinolinium) sulphate | 134-31-6 | 205-137-1 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion | morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion | 7411-47-4 | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H302; H319; H335; H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H335; H315; H412 | ||
| thioquinox(ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline | thioquinox(ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline | 93-75-4 | 202-272-8 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine | tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine | 24602-86-6 | 246-347-3 | substance | Repr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360D ***; H332; H302; H315; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360D ***; H332; H302; H315; H410 | |
| dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile | dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile | 3347-22-6 | 222-098-6 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex | pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H312; H302; H410. Notes: A | |||
| 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate; pyrethrin I | 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate; pyrethrin I | 121-21-1 | 204-455-8 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H312; H302; H410 | |
| 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent- 2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; pyrethrin II | 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent- 2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; pyrethrin II | 121-29-9 | 204-462-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H312; H302; H410 | |
| cinerin I; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | cinerin I; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 25402-06-6 | 246-948-0 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| cinerin II; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate | cinerin II; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate | 121-20-0 | 204-454-2 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| piperidine | piperidine | 110-89-4 | 203-813-0 | substance | Flam. Liq. 2; Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1B | * | Hazard statement codes: H225; H331; H311; H314. Labelling pictogram and signal word: GHS02; GHS06; GHS05; Dgr. Labelling hazard statements: H225; H331; H311; H314 |
| morpholine | morpholine | 110-91-8 | 203-815-1 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H226; H332; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dg. Labelling hazard statements: H226; H332; H312; H302; H314 | |
| dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid | dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid | 2782-57-2 | 220-487-5 | substance | Ox. Sol. 2; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H272; H302; H319; H335; H400; H410. Labelling pictogram and signal word: GHS03; GHS07; GHS09; Dgr. Labelling hazard statements: H272; H302; H319; H335; H410. Supplementary hazard statements: EUH031. Notes: T | |
| troclosene potassium; [1] troclosene sodium [2] | troclosene potassium; [1] troclosene sodium [2] | 2244-21-5 [1] 2893-78-9 [2] | 218-828-8 [1] 220-767-7 [2] | substance | Ox. Sol. 2; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | * | STOT SE 3; | H335: C ≥ 10 % | EUH031: C ≥ 10 % | Hazard statement codes: H272; H302; H319; H335; H400; H410. Labelling pictogram and signal word: GHS03; GHS07; GHS09; Dgr. Labelling hazard statements: H272; H302; H319; H335; H410. Supplementary hazard statements: EUH031. Notes: G |
| troclosene sodium, dihydrate | troclosene sodium, dihydrate | 51580-86-0 | 220-767-7 | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H335; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H335; H410. Supplementary hazard statements: EUH031 | |
| symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion | symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion | 87-90-1 | 201-782-8 | substance | Ox. Sol. 2; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H272; H302; H319; H335; H400; H410. Labelling pictogram and signal word: GHS03; GHS07; GHS09; Dgr. Labelling hazard statements: H272; H302; H319; H335; H410. Supplementary hazard statements: EUH031 | |
| methyl-2,3,5,6-tetrachloro-4-pyridylsulphone; 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine | methyl-2,3,5,6-tetrachloro-4-pyridylsulphone; 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine | 13108-52-6 | 236-035-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H312; H302; H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302; H319; H317 | |
| 2-methylaziridine; propyleneimine | 2-methylaziridine; propyleneimine | 75-55-8 | 200-878-7 | substance | Flam. Liq. 2; Carc. 1B; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Eye Dam. 1; Aquatic Chronic 2 | Carc. 1B; H350: | C ≥ 0.01 % | Hazard statement codes: H225; H350; H330; H310; H300; H318; H411. Labelling pictogram and signal word: GHS02; GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H225; H350; H330; H310; H300; H318; H411 |
| 1,2-dimethylimidazole | 1,2-dimethylimidazole | 1739-84-0 | 217-101-2 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H302; H315; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318 | |
| 1-methylimidazole | 1-methylimidazole | 616-47-7 | 210-484-7 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H312; H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314 | |
| 2-methylpyridine; 2-picoline | 2-methylpyridine; 2-picoline | 109-06-8 | 203-643-7 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H226; H332; H312; H302; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H332; H312; H302; H319; H335 | |
| 4-methylpyridine; 4-picoline | 4-methylpyridine; 4-picoline | 108-89-4 | 203-626-4 | substance | Flam. Liq. 3; Acute Tox. 3 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H226; H311; H332; H302; H319; H335; H315. Labelling pictogram and signal word: GHS02; GHS06; Dgr. Labelling hazard statements: H226; H311; H332; H302; H319; H335; H315 | |
| 6-phenyl-1,3,5-triazine-2,4-diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine | 6-phenyl-1,3,5-triazine-2,4-diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine | 91-76-9 | 202-095-6 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol | ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol | 96-45-7 | 202-506-9 | substance | Repr. 1B; Acute Tox. 4 * | Hazard statement codes: H360D ***; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360D ***; H302 | |
| azaconazole (ISO); 1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole | azaconazole (ISO); 1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole | 60207-31-0 | 262-102-3 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| morpholine-4-carbonyl chloride | morpholine-4-carbonyl chloride | 15159-40-7 | 239-213-0 | substance | Carc. 2; Eye Irrit. 2; Skin Irrit. 2 | Hazard statement codes: H351; H319; H315. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351; H319; H315. Supplementary hazard statements: EUH014 | |
| imazalil (ISO); 1-[2- (allyloxy)-2-(2,4-dichlorophenyl)ethyl]- 1H-imidazole | imazalil (ISO); 1-[2- (allyloxy)-2-(2,4-dichlorophenyl)ethyl]- 1H-imidazole | 35554-44-0 | 252-615-0 | substance | Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H351; H301; H332; H318; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H351; H301; H332; H318; H410 |
| imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | 58594-72-2 [1] 83918-57-4 [2] | 261-351-5 [1] 281-291-3 [2] | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| imazalil sulphate (ISO), aqueous solution; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | imazalil sulphate (ISO), aqueous solution; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | 58594-72-2 [1] 83918-57-4 [2] | 261-351-5 [1] 281-291-3 [2] | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Skin Corr. 1B; | H314: C ≥ 50 % | Skin Irrit. 2; | H315: 30 % ≤ C | < 50 % | Eye Dam. 1; | H318: 15 % ≤ C | < 50 % | Eye Irrit. 2; H319: | 5 % ≤ C < 15 % | Hazard statement codes: H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Wng. Labelling hazard statements: H302; H314; H317; H410 |
| captan (ISO); 1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide | captan (ISO); 1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide | 133-06-2 | 205-087-0 | substance | Carc. 2; Acute Tox. 3 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1 | M=10 | Hazard statement codes: H351; H331; H318; H317; H400. Labelling pictogram and signal word: GHS06; GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H331; H318; H317; H400 |
| folpet (ISO); N-(trichloromethylthio)phthalimide | folpet (ISO); N-(trichloromethylthio)phthalimide | 133-07-3 | 205-088-6 | substance | Carc. 2; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | M=10 | Hazard statement codes: H351; H332; H319; H317; H400. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H332; H319; H317; H400 |
| captafol (ISO); 1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide | captafol (ISO); 1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide | 2425-06-1 | 219-363-3 | substance | Carc. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H317; H410 | |
| 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate; dimetilan (ISO) | 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate; dimetilan (ISO) | 644-64-4 | 211-420-0 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H312; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H312; H410 | |
| carbendazim (ISO); methyl benzimidazol-2-ylcarbamate | carbendazim (ISO); methyl benzimidazol-2-ylcarbamate | 10605-21-7 | 234-232-0 | substance | Muta. 1B; Repr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H340; H360FD; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Dgr. Labelling hazard statements: H340; H360FD; H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| benomyl (ISO); methyl 1-(butylcarbamoyl)benzimidazol- 2-ylcarbamate | benomyl (ISO); methyl 1-(butylcarbamoyl)benzimidazol- 2-ylcarbamate | 17804-35-2 | 241-775-7 | substance | Muta. 1B; Repr. 1B; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H340; H360FD; H335; H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H340; H360FD; H335; H315; H317; H410 |
| carbadox (INN); methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide | carbadox (INN); methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide | 6804-07-5 | 229-879-0 | substance | Flam. Sol. 1; Carc. 1B; Acute Tox. 4 * | Hazard statement codes: H228; H350; H302. Labelling pictogram and signal word: GHS02; GHS08; GHS07; Dgr. Labelling hazard statements: H228; H350; H302. Notes: T | |
| molinate (ISO); S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate | molinate (ISO); S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate | 2212-67-1 | 218-661-0 | substance | Carc. 2; Repr. 2; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | Hazard statement codes: H351; H361f ***; H332; H302; H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H361f ***; H332; H302; H373 **; H317; H410 |
| trifenmorph (ISO); 4-tritylmorpholine | trifenmorph (ISO); 4-tritylmorpholine | 1420-06-0 | 215-812-2 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| anilazine (ISO); 2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline | anilazine (ISO); 2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline | 101-05-3 | 202-910-5 | substance | Eye Irrit. 2; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H315; H410 | |
| thiabendazole (ISO); 2-(thiazol-4-yl)benzimidazole | thiabendazole (ISO); 2-(thiazol-4-yl)benzimidazole | 148-79-8 | 205-725-8 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 |
| 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate; difenzoquat methyl sulfate | 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate; difenzoquat methyl sulfate | 43222-48-6 | 256-152-5 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H302; H410 | |
| dodemorph (ISO); 4-cyclododecyl-2,6- dimethylmorpholine | dodemorph (ISO); 4-cyclododecyl-2,6- dimethylmorpholine | 1593-77-7 | 216-474-9 | substance | Repr. 2; STOT RE 2; Skin Corr. 1C; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H361d; H373 (liver); H314; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H361d; H373 (liver); H314; H317; H410. Supplementary hazard statements: EUH071 |
| permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 52645-53-1 | 258-067-9 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | Hazard statement codes: H332; H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H302; H317; H410 |
| profluralin (ISO); N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine | profluralin (ISO); N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine | 26399-36-0 | 247-656-6 | substance | Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H410 | |
| resmethrin (ISO); 5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate | resmethrin (ISO); 5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate | 10453-86-8 | 233-940-7 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | M=1000 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 |
| 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania | 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania | 15662-33-6 | 239-732-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H410 | |
| sabadilla (ISO); veratrine | sabadilla (ISO); veratrine | 8051-02-3 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H319; H335; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335; H315 | ||
| secbumeton (ISO); 2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | secbumeton (ISO); 2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | 26259-45-0 | 247-554-1 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H410 | |
| 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane; sesamex | 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane; sesamex | 51-14-9 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | ||
| simetryn (ISO); 2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine | simetryn (ISO); 2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine | 1014-70-6 | 213-801-7 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| terbumeton (ISO); 2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | terbumeton (ISO); 2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | 33693-04-8 | 251-637-8 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| propazine(ISO); 2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine | propazine(ISO); 2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine | 139-40-2 | 205-359-9 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| atrazine (ISO); 2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine | atrazine (ISO); 2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine | 1912-24-9 | 217-617-8 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H317; H410 | |
| ε-caprolactam | ε-caprolactam | 105-60-2 | 203-313-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H332; H302; H319; H335; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H302; H319; H335; H315 | |
| propylenethiourea | propylenethiourea | 2122-19-2 | substance | Repr. 2; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H361d ***; H302; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361d ***; H302; H412 | ||
| 2-fluoro-5-trifluoromethylpyridine | 2-fluoro-5-trifluoromethylpyridine | 69045-82-5 | 400-290-2 | substance | Flam. Liq. 3; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H226; H317; H412. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H317; H412 | |
| N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl) methyl)amine | N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl) methyl)amine | 91273-04-0 | 401-280-0 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H411 | |
| N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine | N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine | 10357-99-0 | 401-410-6 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H373 **; H317; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H317; H411 | |
| 3-(3-methylpent-3-yl)isoxazol-5-ylamine | 3-(3-methylpent-3-yl)isoxazol-5-ylamine | 82560-06-3 | 401-460-9 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H331; H301; H318; H412. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H331; H301; H318; H412 | |
| 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione | 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione | 89415-87-2 | 401-570-7 | substance | Ox. Sol. 1 ****; Acute Tox. 3 *; Skin Corr. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H271; H331; H314; H302; H317; H400. Labelling pictogram and signal word: GHS03; GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H271; H331; H314; H302; H317; H400 | |
| 3-chloro-5-trifluoromethyl-2-pyridylamine | 3-chloro-5-trifluoromethyl-2-pyridylamine | 79456-26-1 | 401-670-0 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine | reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine | 401-940-8 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H302; H319; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H411 | ||
| N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino) triazin-2-yl)-4,7-diazadecane-1,10-diamine | N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino) triazin-2-yl)-4,7-diazadecane-1,10-diamine | 106990-43-6 | 401-990-0 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers | 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers | 402-520-7 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H315; H317; H410 | ||
| 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione | 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione | 105254-85-1 | 402-540-6 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H410 | |
| 1-butyl-2-methylpyridinium bromide | 1-butyl-2-methylpyridinium bromide | 26576-84-1 | 402-680-8 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| 2-methyl-1-pentylpyridinium bromide | 2-methyl-1-pentylpyridinium bromide | 402-690-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H312; H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302; H412 | ||
| 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl) phenylsulfonyl)ethyldimethylammonium formate | 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl) phenylsulfonyl)ethyldimethylammonium formate | 402-120-2 | substance | Skin Corr. 1B; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H373 **; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H373 **; H317; H410 | ||
| 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate | 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate | 106359-93-7 | 402-490-5 | substance | Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H410 | |
| reaction mass of 1,1'-(methylenebis(4,1- phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino) benzyl)phenyl)pyrrole-2,5-dione | reaction mass of 1,1'-(methylenebis(4,1- phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino) benzyl)phenyl)pyrrole-2,5-dione | 401-970-1 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | ||
| caffeine | caffeine | 58-08-2 | 200-362-1 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| tetrahydrothiophene | tetrahydrothiophene | 110-01-0 | 203-728-9 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H225; H332; H312; H302; H319; H315; H412. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H332; H312; H302; H319; H315; H412 | |
| 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one | 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one | 2634-33-5 | 220-120-9 | substance | Acute Tox. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 450 mg/kg bw | inhalation: ATE = 0.21 mg/L (dusts or mists) | Skin Sens. 1A; H317: C ≥ 0.036 % | M = 1 | M = 1 | Hazard statement codes: H330; H302; H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H302; H315; H318; H317; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| diquat dibromide; [1] diquat dichloride; [2] 6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] | diquat dibromide; [1] diquat dichloride; [2] 6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] | 85-00-7 [1] 4032-26-2 [2] 94021-76-8 [3] | 201-579-4 [1] 223-714-6 [2] 301-467-6 [3] | substance | Acute Tox. 2 *; STOT RE 1; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H372 **; H302; H319; H335; H315; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H372 **; H302; H319; H335; H315; H317; H410 | |
| paraquat dichloride; 1,1-dimethyl-4,4'-bipyridinium dichloride; [1] paraquat dimethylsulfate; 1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] | paraquat dichloride; 1,1-dimethyl-4,4'-bipyridinium dichloride; [1] paraquat dimethylsulfate; 1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] | 1910-42-5 [1] 2074-50-2 [2] | 217-615-7 [1] 218-196-3 [2] | substance | Acute Tox. 2 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H311; H301; H372 **; H319; H335; H315; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H311; H301; H372 **; H319; H335; H315; H410 | |
| morfamquat dichloride; [1] morfamquat sulfate [2] | morfamquat dichloride; [1] morfamquat sulfate [2] | 4636-83-3 [1] 29873-36-7 [2] | 225-062-8 [1] [2] | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H302; H319; H335; H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H335; H315; H412 | |
| 1,10-phenanthroline | 1,10-phenanthroline | 66-71-7 | 200-629-2 | substance | Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H410 | |
| hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate | hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate | 85153-92-0 | 400-050-7 | substance | Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317 | |
| 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine | 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine | 5248-39-5 | 401-360-5 | substance | Acute Tox. 4 *; STOT RE 2 * | Hazard statement codes: H302; H373 **. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373 ** | |
| sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate | sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate | 92484-48-5 | 403-080-9 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2-amino-6-ethoxy-4-methylamino- 1,3,5-triazine | 2-amino-6-ethoxy-4-methylamino- 1,3,5-triazine | 62096-63-3 | 403-580-7 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | 111298-82-9 | 403-690-5 | substance | Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H334; H317; H412. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317; H412 | |
| N-(n-octyl)-2-pyrrolidone | N-(n-octyl)-2-pyrrolidone | 2687-94-7 | 403-700-8 | substance | Skin Corr. 1B; Aquatic Chronic 2 | Hazard statement codes: H314; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H314; H411 | |
| 1-dodecyl-2-pyrrolidone | 1-dodecyl-2-pyrrolidone | 2687-96-9 | 403-730-1 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H410 | |
| 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione | 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione | 404-230-6 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| N—tert-pentyl-2-benzothiazolesulfenamide | N—tert-pentyl-2-benzothiazolesulfenamide | 110799-28-5 | 404-380-2 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| dimethomorph (ISO); 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine | dimethomorph (ISO); 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine | 110488-70-5 | 404-200-2 | substance | Repr. 1B; Aquatic Chronic 2 | Hazard statement codes: H360F; H411. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360F; H411. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| sodium 5-n-butylbenzotriazole | sodium 5-n-butylbenzotriazole | 118685-34-0 | 404-450-2 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H317; H411 | |
| 5-tert-butyl-3-isoxazolylamine hydrochloride | 5-tert-butyl-3-isoxazolylamine hydrochloride | 404-840-2 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H373 **; H318; H412. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H302; H373 **; H318; H412 | ||
| hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino (6-morpholino-1,3,5-triazine-4,2-diyl) imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) | hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino (6-morpholino-1,3,5-triazine-4,2-diyl) imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) | 124537-30-0 | 405-160-9 | substance | Acute Tox. 3 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H301; H317; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H317; H412 | |
| tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl- 5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate | tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl- 5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate | 405-240-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2- diyl)imino)dibenzene-1,4-disulfonate | hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2- diyl)imino)dibenzene-1,4-disulfonate | 76508-02-6 | 405-280-1 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| benzothiazole-2-thiol | benzothiazole-2-thiol | 149-30-4 | 205-736-8 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| bis(piperidinothiocarbonyl) disulphide | bis(piperidinothiocarbonyl) disulphide | 94-37-1 | 202-328-1 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H335; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335; H315; H317 | |
| dimepiperate (ISO); S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate | dimepiperate (ISO); S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate | 61432-55-1 | 262-784-2 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 1,2,4-triazole | 1,2,4-triazole | 288-88-0 | 206-022-9 | substance | Repr. 1B; Acute Tox. 4; Eye Irrit. 2 | Oral: ATE = 1320 mg/kg bw | Hazard statement codes: H360FD; H302; H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360FD; H302; H319. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| octhilinone (ISO); 2-octyl-2H-isothiazol- 3-one; [OIT] | octhilinone (ISO); 2-octyl-2H-isothiazol- 3-one; [OIT] | 26530- 20-1 | 247-761-7 | substance | Acute Tox. 2; Acute Tox. 3; Acute Tox. 3; Skin Corr. 1; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 0.27 mg/L (dusts or mists) | dermal: ATE = 311 mg/kg bw | oral: ATE = 125 mg/kg bw | Skin Sens. 1A; H317: C ≥ 0.0015 % | M = 100 | M = 100 | Hazard statement codes: H330; H311; H301; H314; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H311; H301; H314; H317; H410. Supplementary hazard statements: EUH071 |
| 2-(morpholinothio)benzothiazole | 2-(morpholinothio)benzothiazole | 102-77-2 | 203-052-4 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H319; H315; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H315; H317; H411 | |
| 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol; 1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine | 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol; 1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine | 4719-04-4 | 225-208-0 | substance | Acute Tox. 4 *; Skin Sens. 1 | Skin Sens. 1; | H317: C ≥ 0.1 % | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 |
| hymexazol (ISO); 3-hydroxy-5-methylisoxazole | hymexazol (ISO); 3-hydroxy-5-methylisoxazole | 10004- 44-1 | 233-000-6 | substance | Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | oral: ATE = 1600 mg/kg bw | Hazard statement codes: H361d; H302; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS05; GHS09; Dgr. Labelling hazard statements: H361d; H302; H318; H317; H411 |
| tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 731-27-1 | 211-986-9 | substance | Acute Tox. 2 *; STOT RE 1; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | M=10 | Hazard statement codes: H330; H372**; H319; H335; H315; H317; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H372**; H319; H335; H315; H317; H400 |
| tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 731-27-1 | 211-986-9 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | M=10 | Hazard statement codes: H319; H335; H315; H317; H400. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H335; H315; H317; H400 |
| diniconazole (ISO); (E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol; (E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol | diniconazole (ISO); (E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol; (E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol | 76714-88-0 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | ||
| flubenzimine (ISO); N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline | flubenzimine (ISO); N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline | 37893-02-0 | 253-703-1 | substance | Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H410 | |
| (benzothiazol-2-ylthio)methyl thiocyanate; TCMTB | (benzothiazol-2-ylthio)methyl thiocyanate; TCMTB | 21564-17-0 | 244-445-0 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H302; H319; H315; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H302; H319; H315; H317; H410 | |
| bioresmethrin (ISO); (5-benzyl-3-furyl)methyl (1R)-2,2- dimethyl-3-(2-methylprop-1-en-1- yl)cyclopropanecarboxylate | bioresmethrin (ISO); (5-benzyl-3-furyl)methyl (1R)-2,2- dimethyl-3-(2-methylprop-1-en-1- yl)cyclopropanecarboxylate | 28434-01-7 | 249-014-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 |
| chlorsulfuron (ISO); 2- chloro-N-[[(4-methoxy- 6-methyl-1,3,5-triazin- 2- yl)amino]carbonyl] benzenesulphonamide | chlorsulfuron (ISO); 2- chloro-N-[[(4-methoxy- 6-methyl-1,3,5-triazin- 2- yl)amino]carbonyl] benzenesulphonamide | 64902-72-3 | 265-268-5 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | M = 100 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 |
| diclobutrazole (ISO); (R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol | diclobutrazole (ISO); (R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol | 75736-33-3 | substance | Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H319; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H411 | ||
| 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem | 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem | 33813-20-6 | 251-684-4 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| fenpropimorph (ISO); cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine | fenpropimorph (ISO); cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine | 67564-91-4 | 266-719-9 | substance | Repr. 2; Acute Tox. 4 *; Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H361d ***; H302; H315; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d ***; H302; H315; H411 | |
| hexythiazox (ISO); trans-5-(4-chlorophenyl)-N-cyclohexyl-4- methyl-2-oxo-3-thiazolidine-carboxamide | hexythiazox (ISO); trans-5-(4-chlorophenyl)-N-cyclohexyl-4- methyl-2-oxo-3-thiazolidine-carboxamide | 78587- 05-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| imazapyr (ISO); 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate | imazapyr (ISO); 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate | 81334-34-1 | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | ||
| 1,1-dimethylpiperidinium chloride; mepiquat chloride | 1,1-dimethylpiperidinium chloride; mepiquat chloride | 24307-26-4 | 246-147-6 | substance | Acute Tox. 3; Acute Tox. 4; Aquatic Chronic 3 | oral: ATE = 270 mg/kg bw | inhalation: ATE = 2.8 mg/L | (dusts or mists) | Hazard statement codes: H301; H332; H412. Labelling pictogram and signal word: GHS06; Wng. Labelling hazard statements: H301; H332; H412. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| prochloraz (ISO); N-propyl-N-[2-(2,4,6-trichlorophenoxy) ethyl]-1H-imidazole-1-carboxamide | prochloraz (ISO); N-propyl-N-[2-(2,4,6-trichlorophenoxy) ethyl]-1H-imidazole-1-carboxamide | 67747-09-5 | 266-994-5 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| metamitron (ISO); 4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one | metamitron (ISO); 4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one | 41394-05-2 | 255-349-3 | substance | Acute Tox. 4 *; Aquatic Acute 1 | Hazard statement codes: H302; H400. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H400 | |
| pyroquilon (ISO); 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one | pyroquilon (ISO); 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one | 57369-32-1 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | ||
| hexazinone (ISO); 3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione | hexazinone (ISO); 3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione | 51235-04-2 | 257-074-4 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H410 | |
| etridiazole (ISO); 5-ethoxy-3-trichloromethyl- 1,2,4-thiadiazole | etridiazole (ISO); 5-ethoxy-3-trichloromethyl- 1,2,4-thiadiazole | 2593-15-9 | 219-991-8 | substance | Carc. 2; Acute Tox. 4; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H351; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H317; H410 |
| myclobutanil(ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile | myclobutanil(ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile | 88671-89-0 | substance | Repr. 2; Acute Tox. 4 *; Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H361d ***; H302; H319; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d ***; H302; H319; H411 | ||
| di(benzothiazol-2-yl) disulphide | di(benzothiazol-2-yl) disulphide | 120-78-5 | 204-424-9 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410. Supplementary hazard statements: EUH031 | |
| N-cyclohexylbenzothiazole-2-sulphenamide | N-cyclohexylbenzothiazole-2-sulphenamide | 95-33-0 | 202-411-2 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| methabenzthiazuron (ISO); 1-(1,3-benzothiazol-2-yl)1,3-dimethylurea | methabenzthiazuron (ISO); 1-(1,3-benzothiazol-2-yl)1,3-dimethylurea | 18691-97-9 | 242-505-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| quinoxyfen (ISO); 5,7-dichloro-4-(4-fluorophenoxy)quinoline | quinoxyfen (ISO); 5,7-dichloro-4-(4-fluorophenoxy)quinoline | 124495-18-7 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | ||
| metsulfuron-methyl (ISO); methyl 2-{[(4-methoxy-6-methyl-1,3,5- triazin-2-yl)carbamoyl]sulfamoyl}benzoate | metsulfuron-methyl (ISO); methyl 2-{[(4-methoxy-6-methyl-1,3,5- triazin-2-yl)carbamoyl]sulfamoyl}benzoate | 74223-64-6 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| cycloheximide (ISO); 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione | cycloheximide (ISO); 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione | 66-81-9 | 200-636-0 | substance | Muta. 2; Repr. 1B; Acute Tox. 2 *; Aquatic Chronic 2 | Hazard statement codes: H341; H360D ***; H300; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H341; H360D ***; H300; H411 | |
| 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone | 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone | 93686-63-6 | 401-470-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate | trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate | 405-860-4 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| 1-(3-phenylpropyl)-2-methylpyridinium bromide | 1-(3-phenylpropyl)-2-methylpyridinium bromide | 10551-42-5 | 405-930-4 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H302; H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H412 | |
| reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate | reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate | 125139-08-4 | 406-460-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolinium 4-methylbenzenesulfonate | (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolinium 4-methylbenzenesulfonate | 77497-97-3 | 406-960-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| N-ethyl-N-methylpiperidinium iodide | N-ethyl-N-methylpiperidinium iodide | 4186-71-4 | 407-780-5 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy) ethyl]morpholine | 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy) ethyl]morpholine | 111681-72-2 | 407-940-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5- triazin-2-ylamino)ethane | tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5- triazin-2-ylamino)ethane | 143683-23-2 | 411-240-4 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| pyridaben (ISO); 2-tert-butyl-5-(4-tert- butylbenzylthio)-4- chloropyridazin-3 (2H)-one | pyridaben (ISO); 2-tert-butyl-5-(4-tert- butylbenzylthio)-4- chloropyridazin-3 (2H)-one | 96489-71-3 | 405-700-3 | substance | Acute Tox. 3; Acute Tox. 3; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | M = 1 000 | Hazard statement codes: H331; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H301; H410 |
| 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione | 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione | 406-295-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine | 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine | 104218-44-2 | 406-360-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate | phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate | 89392-03-0 | 406-600-2 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 2,3,5-trichloropyridine | 2,3,5-trichloropyridine | 16063-70-0 | 407-270-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 2-amino-4-chloro-6-methoxypyrimidine | 2-amino-4-chloro-6-methoxypyrimidine | 5734-64-5 | 410-050-9 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 5-chloro-2,3-difluoropyridine | 5-chloro-2,3-difluoropyridine | 89402-43-7 | 410-090-7 | substance | Flam. Liq. 3; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H226; H302; H412. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H302; H412 | |
| 2-butyl-4-chloro-5-formylimidazole | 2-butyl-4-chloro-5-formylimidazole | 83857-96-9 | 410-260-0 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 2,4-diamino-5-methoxymethylpyrimidine | 2,4-diamino-5-methoxymethylpyrimidine | 54236-98-5 | 410-330-0 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2 | Hazard statement codes: H302; H373 **; H319. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373 **; H319 | |
| 2,3-dichloro-5-trifluoromethyl-pyridine | 2,3-dichloro-5-trifluoromethyl-pyridine | 69045-84-7 | 410-340-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H332; H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H332; H302; H318; H317; H411 | |
| fenazaquin (ISO); 4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy] quinazoline | fenazaquin (ISO); 4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy] quinazoline | 120928-09-8 | 410-580-0 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H332; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H332; H410 | |
| (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide | (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide | 125224-62-6 | 411-000-9 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| (2,4-diaminopteridin-6-yl)methanol hydrobromide | (2,4-diaminopteridin-6-yl)methanol hydrobromide | 76145-91-0 | 430-620-0 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H373**; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H373**; H317; H412 | |
| (6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide | (6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide | 100988-63-4 | 423-260-0 | substance | Muta. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H341; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H341; H317; H411 | |
| azimsulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea | azimsulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea | 120162-55-2 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M=1000 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| flufenacet (ISO); N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide | flufenacet (ISO); N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide | 142459-58-3 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H302; H373**; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H317; H410 | |
| flupyrsulfuron-methyl-sodium (ISO); methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt | flupyrsulfuron-methyl-sodium (ISO); methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt | 144740-54-5 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| flumioxazin (ISO); N-(7-fluoro-3,4-dihydro- 3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin- 6-yl)cyclohex-1-ene-1,2-dicarboximide | flumioxazin (ISO); N-(7-fluoro-3,4-dihydro- 3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin- 6-yl)cyclohex-1-ene-1,2-dicarboximide | 103361-09-7 | substance | Repr. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | M = 1000 | Hazard statement codes: H361d; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| reaction mass of 5-chloro-2- methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3- one (3:1) | reaction mass of 5-chloro-2- methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3- one (3:1) | 55965-84-9 | substance | Acute Tox. 2; Acute Tox. 2; Acute Tox. 3; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | Skin Corr. 1C; H314: | C ≥ 0.6 % | Skin Irrit. 2; H315: | 0.06 % ≤ C < 0.6 % | Eye Dam. 1; H318: | C ≥ 0.6 % | Eye Irrit. 2; H319: | 0.06 % ≤ C < 0.6 % | Skin Sens. 1A; H317: | C ≥ 0.0015 % | M=100 | M=100 | Hazard statement codes: H330; H310; H301; H314; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H310; H301; H314; H317; H410. Supplementary hazard statements: EUH071. Notes: B | |
| 1-vinyl-2-pyrrolidone | 1-vinyl-2-pyrrolidone | 88-12-0 | 201-800-4 | substance | Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; STOT SE 3; Eye Dam. 1 | Hazard statement codes: H351; H332; H312; H302; H373 **; H335; H318. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H351; H332; H312; H302; H373 **; H335; H318. Notes: D | |
| 9-vinylcarbazole | 9-vinylcarbazole | 1484-13-5 | 216-055-0 | substance | Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H341; H312; H302; H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H341; H312; H302; H315; H317; H410 |
| 2,2-ethylmethylthiazolidine | 2,2-ethylmethylthiazolidine | 694-64-4 | 404-500-3 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | |
| hexaconazole (ISO); (RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol | hexaconazole (ISO); (RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol | 79983-71-4 | 413-050-7 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| 5-chloro-1,3-dihydro-2H-indol-2-one | 5-chloro-1,3-dihydro-2H-indol-2-one | 17630-75-0 | 412-200-9 | substance | Repr. 2; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H361f ***; H302; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361f ***; H302; H317; H412 | |
| fluquinconazole (ISO); 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one | fluquinconazole (ISO); 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one | 136426-54-5 | 411-960-9 | substance | Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H301; H372 **; H312; H315; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H301; H372 **; H312; H315; H410 | |
| tetraconazole (ISO); (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether | tetraconazole (ISO); (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether | 112281-77-3 | 407-760-6 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H332; H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H302; H411 | |
| epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4- fluorophenyl)-[( 1H-1,2,4-triazol-1- yl)methyl]oxirane | epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4- fluorophenyl)-[( 1H-1,2,4-triazol-1- yl)methyl]oxirane | 133855-98-8 | 406-850-2 | substance | Carc. 2; Repr. 1B; Aquatic Chronic 2 | Hazard statement codes: H351; H360Df; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H360Df; H411 | |
| 2-methyl-2-azabicyclo[2.2.1]heptane | 2-methyl-2-azabicyclo[2.2.1]heptane | 4524-95-2 | 404-810-9 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1B | Hazard statement codes: H226; H312; H302; H373 **; H314. Labelling pictogram and signal word: GHS02; GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H312; H302; H373 **; H314 | |
| 8-amino-7-methylquinoline | 8-amino-7-methylquinoline | 5470-82-6 | 412-760-4 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H317; H411 | |
| 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine | 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine | 137796-06-6 | 410-470-2 | substance | Skin Corr. 1B; Skin Sens. 1 | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H314; H317 |
| lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide | lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide | 111337-53-2 | 411-690-1 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314; H317; H411 | |
| N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide | N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide | 3741-80-8 | 407-430-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl) cinnamylidenehydrazone | 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl) cinnamylidenehydrazone | 67485-29-4 | 405-090-9 | substance | STOT RE 1; Acute Tox. 4 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H372 **; H302; H319; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H372 **; H302; H319; H410 | |
| 1-(1-naphthylmethyl)quinolinium chloride | 1-(1-naphthylmethyl)quinolinium chloride | 65322-65-8 | 406-220-7 | substance | Carc. 2; Muta. 2; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H351; H341; H302; H315; H318; H412. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H351; H341; H302; H315; H318; H412 | |
| reaction mass of: 5-(N-methylperfluorooctylsulfonamido) methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido) methyl-3-octadecyl-1,3-oxazolidin-2-one | reaction mass of: 5-(N-methylperfluorooctylsulfonamido) methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido) methyl-3-octadecyl-1,3-oxazolidin-2-one | 413-640-4 | substance | STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H410 | ||
| nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate | nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate | 413-670-8 | substance | Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317 | ||
| 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta [d]-1,2-thiazol-3-one | 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta [d]-1,2-thiazol-3-one | 82633-79-2 | 407-630-9 | substance | Acute Tox. 3 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H301; H318; H317; H410 | |
| 2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy) ethyl)-4-oxoazetidin-2-yl acetate | 2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy) ethyl)-4-oxoazetidin-2-yl acetate | 76855-69-1 | 408-050-9 | substance | Eye Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H319; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H317; H411 | |
| 5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene | 5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene | 410-530-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone | 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone | 116256-11-2 | 411-500-7 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | |
| 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane | 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane | 52667-88-6 | 414-030-0 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| disodium 1-amino-4-(2-(5-chloro-6-fluoropyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro- anthracene-2-sulfonate | disodium 1-amino-4-(2-(5-chloro-6-fluoropyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro- anthracene-2-sulfonate | 149530-93-8 | 414-040-5 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine | 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine | 143860-04-2 | 421-150-7 | substance | Repr. 1B; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360F ***; H314; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H360F ***; H314; H410 | |
| 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane | 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane | 151860-15-0 | 426-750-2 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di [phthalocyaninecopper(II)]] heptalactate | pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di [phthalocyaninecopper(II)]] heptalactate | 414-930-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt | 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt | 163062-28-0 | 418-000-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one) | 2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one) | 18600-59-4 | 418-280-1 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl] amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl] azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt | 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl] amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl] azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt | 168113-78-8 | 418-380-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine | reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine | 187547-46-2 | 420-390-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine | 2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine | 145963-84-4 | 415-500-8 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H302; H373**; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373**; H412 | |
| reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione; reaction mass of oligomers of 3,5-bis (3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione | reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione; reaction mass of oligomers of 3,5-bis (3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione | 421-550-1 | substance | Carc. 1B; Repr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H350; H360D ***; H317; H412. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H360D ***; H317; H412 | ||
| Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts | Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts | 420-980-7 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole | (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole | 143322-57-0 | 422-390-5 | substance | Repr. 2; STOT RE 1; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361f ***; H372 **; H332; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H361f ***; H372 **; H332; H302; H317; H410. Supplementary hazard statements: EUH070 | |
| pymetrozine (ISO); (E)-4,5-dihydro-6- methyl-4-(3-pyridylmethyleneamino)- 1,2,4-triazin-3(2H)- one | pymetrozine (ISO); (E)-4,5-dihydro-6- methyl-4-(3-pyridylmethyleneamino)- 1,2,4-triazin-3(2H)- one | 123312- 89-0 | substance | Carc. 2; Repr. 2; Aquatic Chronic 1 | M = 1 | Hazard statement codes: H351; H361fd; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H361fd; H410 | |
| pyraflufen-ethyl (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2] | pyraflufen-ethyl (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2] | 129630-19-9 [1] 129630-17-7 [2] | -[1] -[2] | substance | Aquatic Acute 1; Aquatic Chronic 1 | M=1000 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 |
| oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)- 1,3,4-oxadiazol-2(3H)-one | oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)- 1,3,4-oxadiazol-2(3H)-one | 39807-15-3 | 254-637-6 | substance | Repr. 2; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | Hazard statement codes: H361d***; H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d***; H373**; H410 |
| propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazole | propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazole | 60207-90-1 | 262-104-4 | substance | Repr. 1B; Acute Tox. 4; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H360D; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360D; H302; H317; H410 |
| fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one | fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one | 161326-34-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid | imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid | 114311-32-9 | substance | Repr. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H361d; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride | cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride | 63645-17-0 | 417-430-3 | substance | Acute Tox. 3 *; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H301; H373 **; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H373 **; H317; H411 | |
| 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane | 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane | 88128-57-8 | 417-650-1 | substance | STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H373 **; H412. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H373 **; H412 | |
| N-methyl-4-(p-formylstyryl)pyridinium methylsulfate | N-methyl-4-(p-formylstyryl)pyridinium methylsulfate | 74401-04-0 | 418-240-3 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) | 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) | 133467-41-1 | 418-320-8 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline | cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline | 120807-02-5 | 416-040-0 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide | N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide | 147613-95-4 | 416-260-7 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-chloromethyl-3,4-dimethoxypyridinium chloride | 2-chloromethyl-3,4-dimethoxypyridinium chloride | 72830-09-2 | 416-440-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H373 **; H315; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H373 **; H315; H318; H317; H411 | |
| 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole | 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole | 162208-01-7 | 416-490-8 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6, 6-tetramethylpiperidine | 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6, 6-tetramethylpiperidine | 73754-27-5 | 416-770-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 6-hydroxyindole | 6-hydroxyindole | 2380-86-1 | 417-020-4 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | |
| 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole | 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole | 79185-77-6 | 417-140-7 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide | trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide | 147086-81-5 | 417-290-3 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 2-chloro-5-methyl-pyridine | 2-chloro-5-methyl-pyridine | 18368-64-4 | 418-050-0 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H312; H302; H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302; H315; H412 | |
| 4-(1-oxo-2-propenyl)-morpholine | 4-(1-oxo-2-propenyl)-morpholine | 5117-12-4 | 418-140-1 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H373 **; H318; H317. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H302; H373 **; H318; H317 | |
| N-isopropyl-3-(4-fluorophenyl)-1H-indole | N-isopropyl-3-(4-fluorophenyl)-1H-indole | 93957-49-4 | 418-790-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2,5-dimercaptomethyl-1,4-dithiane | 2,5-dimercaptomethyl-1,4-dithiane | 136122-15-1 | 419-770-8 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H317; H410 | |
| reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. | reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. | 421-290-9 | substance | STOT RE 2 *; Aquatic Chronic 4 | Hazard statement codes: H373 **; H413. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H373 **; H413 | ||
| 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl) amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride | 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl) amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride | 163831-67-2 | 420-950-3 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 99199-90-3 | 419-600-2 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 793669-26-8 | 419-630-6 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine | 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine | 106917-31-1 | 411-930-5 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H317; H410 | |
| florasulam (ISO); 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; pyrimidine-2-sulfonanilide | florasulam (ISO); 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; pyrimidine-2-sulfonanilide | 145701-23-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| 2,6-diamino-3-((pyridine-3-yl) azo)pyridine | 2,6-diamino-3-((pyridine-3-yl) azo)pyridine | 28365-08-4 | 421-430-9 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H302; H373**; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H411 | |
| 3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide | 3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide | 163269-30-5 | 431-030-6 | substance | Acute Tox. 3 *; STOT RE 2 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H373**; H318; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H373**; H318; H410 | |
| 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane | 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane | 56552-15-9 | 423-230-7 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| imidazo[1,2-b]pyridazin hydrochloride | imidazo[1,2-b]pyridazin hydrochloride | 18087-70-2 | 431-510-5 | substance | Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319 | |
| 2,3-dihydro-2,2-dimethyl-1H-perimidin | 2,3-dihydro-2,2-dimethyl-1H-perimidin | 6364-17-6 | 424-060-6 | substance | Acute Tox. 4*; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373**; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H317; H410 | |
| 2-chloro-3-trifluoromethylpyridine | 2-chloro-3-trifluoromethylpyridine | 65753-47-1 | 424-520-6 | substance | Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H311; H301; H372**; H314; H412. Labelling pictogram and signal word: GHS06; GHS05; GHS08; Dgr. Labelling hazard statements: H311; H301; H372**; H314; H412 | |
| 6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine | 6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine | 133949-92-5 | 424-950-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl) amino]phenyl]sulfonyl]ethyl sulfate | sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl) amino]phenyl]sulfonyl]ethyl sulfate | 81992-66-7 | 430-890-1 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| 2-[3-(methylamino)propyl]-1H-benzimidazole | 2-[3-(methylamino)propyl]-1H-benzimidazole | 64137-52-6 | 425-760-4 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| 3-(2H-tetrazol-5-yl)pyridine | 3-(2H-tetrazol-5-yl)pyridine | 3250-74-6 | 426-810-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts | reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts | 191877-09-5 | 426-860-0 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 4,4’-(1,6-hexamethylenebis (formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) | 4,4’-(1,6-hexamethylenebis (formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) | 182235-14-9 | 427-350-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 5,7-dichloro-4-hydroxyquinoline | 5,7-dichloro-4-hydroxyquinoline | 21873-52-9 | 427-420-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2-fluoro-6-trifluoromethylpyridine | 2-fluoro-6-trifluoromethylpyridine | 94239-04-0 | 428-100-3 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H226; H332; H302; H412. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H332; H302; H412 | |
| 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine | 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine | 103577-66-8 | 428-200-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole | 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole | 107786-36-7 | 428-910-7 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 3,4-dimethyl-1H-pyrazole | 3,4-dimethyl-1H-pyrazole | 2820-37-3 | 429-130-1 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | |
| 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate | 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate | 155601-30-2 | 429-300-3 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | |
| reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine | reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine | 429-990-6 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | ||
| (R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl) ethenyl]-1H-indole | (R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl) ethenyl]-1H-indole | 180637-89-2 | 430-560-5 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H373**; H318; H317. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H302; H373**; H318; H317 | |
| 2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5) | 2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5) | 430-580-4 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411. Supplementary hazard statements: EUH019 | ||
| forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea | forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea | 68157-60-8 | substance | Carc. 2; Aquatic Chronic 2 | Hazard statement codes: H351; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H411 | ||
| reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl) {][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl] [2-(4-aminoethylpiperazine-1-yl) ethylsulfamoyl{](sulfamoyl)[} (sulfonatophthalocyaninato)] copper(II) | reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl) {][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl] [2-(4-aminoethylpiperazine-1-yl) ethylsulfamoyl{](sulfamoyl)[} (sulfonatophthalocyaninato)] copper(II) | 424-270-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| 3’5’-anhydro thymidine | 3’5’-anhydro thymidine | 38313-48-3 | 425-810-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate | 2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate | 170222-39-6 | 426-400-9 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt | reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt | 202420-04-0 | 427-730-6 | substance | Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H314; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314; H412 | |
| imiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate | imiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate | 72963- 72-5 | 428-790-6 | substance | Carc. 2; Acute Tox. 4; Acute Tox. 4; STOT SE 2; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 1.4 mg/L (dusts or mists) | oral: ATE = 550 mg/kg bw | M = 10 | M = 10 | Hazard statement codes: H351; H332; H302; H371 (nervous system, oral, inhalation); H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H332; H302; H371 (nervous system; oral, inhalation); H410 |
| (±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy (1-methyl-1H-imidazol-5-yl)methyl] -1-methyl-2(1H)-quinolin | (±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy (1-methyl-1H-imidazol-5-yl)methyl] -1-methyl-2(1H)-quinolin | 430-730-9 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | ||
| pyrazole-1-carboxamidine monohydrochloride | pyrazole-1-carboxamidine monohydrochloride | 4023-02-3 | 429-520-1 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H373**; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H302; H373**; H318; H317; H412 | |
| disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene | disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene | 180850-95-7 | 427-310-2 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate | monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate | 429-570-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 2-chloro-5-chloromethylthiazole | 2-chloro-5-chloromethylthiazole | 105827-91-6 | 429-830-5 | substance | Acute Tox. 3 *; Skin Corr. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H311; H314; H302; H317; H411. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H311; H314; H302; H317; H411 | |
| thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine | thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine | 153719-23-4 | 428-650-4 | substance | Repr. 2; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1 | Oral: ATE = 780 mg/kg bw | M = 10 | M = 10 | Hazard statement codes: H361fd; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H361fd; H302; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| (4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine | (4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine | 151213-39-7 | 425-930-8 | substance | Skin Corr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H314; H332; H302; H373**; H411. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H332; H302; H373**; H411 | |
| 2-thiazolidinylidenecyanamide | 2-thiazolidinylidenecyanamide | 26364-65-8 | 427-720-1 | substance | Acute Tox. 4*; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H302; H373**; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373**; H412 | |
| 5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide | 5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide | 113171-13-4 | 428-150-6 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| tritosulfuron (ISO) (containing ≤ 0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT) | tritosulfuron (ISO) (containing ≤ 0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT) | 142469-14-5 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| pyraclostrobin (ISO); methyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[} (N-methoxy)carbamate | pyraclostrobin (ISO); methyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[} (N-methoxy)carbamate | 175013-18-0 | substance | Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; STOT RE 2; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 0.58 mg/L (dusts or mists) | oral: ATE = 450 mg/kg bw | M = 100 | M = 100 | Hazard statement codes: H361d; H331; H302; H335; H373 (liver,; gastrointestinal; tract, nasal; cavity); H315; H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H361d; H331; H302; H335; H373 (liver,; gastrointestinal; tract, nasal; cavity); H315; H410. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine | tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine | 192439-46-6 | 427-600-9 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2,6-dichloro-1-fluoropyridiniumtetrafluoroborate | 2,6-dichloro-1-fluoropyridiniumtetrafluoroborate | 140623-89-8 | 427-400-1 | substance | Skin Corr. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H302; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H302; H317; H410 | |
| 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2- methyl-4H-pyrido[1,2-a] pyrimidin-4- one monohydrochloride | 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2- methyl-4H-pyrido[1,2-a] pyrimidin-4- one monohydrochloride | 93076-03-0 | 424-530-0 | substance | Acute Tox. 3 *; STOT SE 2; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H301; H371**; H373**; H318; H317; H411. Labelling pictogram and signal word: GHS06; GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H371**; H373**; H318; H317; H411 | |
| 1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one | 1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one | 98377-35-6 | 426-110-2 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one | (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one | 427-070-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (3-aminophenyl)pyridin-3-ylmethanone | (3-aminophenyl)pyridin-3-ylmethanone | 79568-06-2 | 428-230-0 | substance | STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373**; H410 | |
| 2-ethyl-2,3-dihydro-2-methyl-1H-perimidine | 2-ethyl-2,3-dihydro-2-methyl-1H-perimidine | 43057-68-7 | 424-380-6 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H410 | |
| tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea | 7226-23-5 | 230-625-6 | substance | Repr. 2; Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H361f***; H302; H318. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H361f***; H302; H318 | |
| quinoline | quinoline | 91-22-5 | 202-051-6 | substance | Carc. 1B; Muta. 2; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H312; H302; H319; H315; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H341; H312; H302; H319; H315; H411 | |
| triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | 138182-18-0 | substance | Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H361f; H373; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361f; H373; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| ketoconazole; 1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl] methoxy]phenyl]piperazin-1-yl] ethanone | ketoconazole; 1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl] methoxy]phenyl]piperazin-1-yl] ethanone | 65277-42-1 | 265-667-4 | substance | Repr. 1B; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360F***; H301; H373**; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H360F***; H301; H373**; H410 | |
| metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | 125116-23-6 | substance | Repr. 2; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H361d***; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d***; H302; H411 | ||
| 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] | 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] | 2592-95-2 [1] 123333-53-9 [2] | 219-989-7 [1] 219-989-7 [2] | substance | Expl. 1.3 | Hazard statement codes: H203. Labelling pictogram and signal word: GHS01; Dgr. Labelling hazard statements: H203 | |
| potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)] | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)] | 183196-57-8 | 418-260-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | 183196-57-8 | 418-260-2 | substance | Repr. 1B; Skin Sens. 1 | Hazard statement codes: H360D***; H317. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360D***; H317 | |
| 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole | 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole | 160194-26-3 | 419-540-7 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | 135756-61-5 | 420-930-4 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | |
| 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole | 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole | 142623-48-1 | 432-020-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride | 189012-93-9 | 432-470-1 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H410 | |
| 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one | 106461-41-0 | 434-820-9 | substance | STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373**; H410 | |
| N,N’,N’’-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | N,N’,N’’-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | 26157-73-3 | 435-010-8 | substance | Muta. 2; Aquatic Chronic 3 | Hazard statement codes: H341; H412. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H341; H412 | |
| 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl) carbamoyloxy]-1H-pyrrolo[1,2-b] [1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester | 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl) carbamoyloxy]-1H-pyrrolo[1,2-b] [1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester | 444065-11-6 | 448-050-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo [1,5-b][1,2,4]triazol-2-yl) phenylcarbamoyl]methylester | 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo [1,5-b][1,2,4]triazol-2-yl) phenylcarbamoyl]methylester | 379268-96-9 | 448-260-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f] [1,2]thiazepine hydrochloride | 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f] [1,2]thiazepine hydrochloride | 363138-44-7 | 448-720-8 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | |
| pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate | pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate | 418-270-7 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | ||
| 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole | 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole | 420-820-6 | substance | Flam. Liq. 3; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H226; H302; H411. Labelling pictogram and signal word: GHS02; GHS07; GHS09; Wng. Labelling hazard statements: H226; H302; H411 | ||
| bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate | 421-560-6 | substance | STOT RE 2 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H373**; H318; H411. Labelling pictogram and signal word: GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H373**; H318; H411 | ||
| main component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt; main component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt; main component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt; main component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt | main component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt; main component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt; main component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt; main component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt | 422-610-1 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| 1-imidazol-1-yl-octadecan-2-ol | 1-imidazol-1-yl-octadecan-2-ol | 434-120-3 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| dimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate | dimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate | 443-910-7 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | 243858-60-8 | 432-980-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2-(1-methyl-2-(4-phenoxyphenoxy) ethoxy)pyridine | 2-(1-methyl-2-(4-phenoxyphenoxy) ethoxy)pyridine | 95737-68-1 | 429-800-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide | 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide | 138937-28-7 | 421-170-6 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | |
| 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole | 3147-77-1 | 448-630-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate | 82911-69-1 | 433-520-5 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine | clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine | 210880-92-5 | 433-460-1 | substance | Repr. 2; Acute Tox. 4; STOT SE 1; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 390 mg/kg bw | M = 10 | M = 100 | Hazard statement codes: H361f; H302; H370 (nervous system); H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Dgr. Labelling hazard statements: H361f; H302; H370 (nervous system); H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| 2-amino-5-methylthiazole | 2-amino-5-methylthiazole | 7305-71-7 | 423-800-5 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H400; H410 | |
| 1-methyl-3-phenyl-1-piperazine | 1-methyl-3-phenyl-1-piperazine | 5271-27-2 | 431-180-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H312; H302; H315; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H315; H318; H412 | |
| (-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride | (-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride | 105813-13-6 | 432-360-3 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| methyl-5-nitrophenyl-guanidine | methyl-5-nitrophenyl-guanidine | 152460-07-6 | 435-500-1 | substance | Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H319; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H317; H412 | |
| 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | 420-200-5 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317; H412 | ||
| 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3 (2H)-dione | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3 (2H)-dione | 173838-67-0 | 442-780-9 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one | 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one | 7693-82-5 | 443-770-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | 430-390-1 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H332; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H412 | ||
| trimethylopropane tri(3-aziridinylpropanoate); (TAZ) | trimethylopropane tri(3-aziridinylpropanoate); (TAZ) | 52234-82-9 | 257-765-0 | substance | Muta. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H341; H318; H317. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H341; H318; H317 | |
| penconazole (ISO); 1- [2-(2,4-dichlorophenyl) pentyl]-1H-1,2,4-triazole | penconazole (ISO); 1- [2-(2,4-dichlorophenyl) pentyl]-1H-1,2,4-triazole | 66246-88-6 | 266-275-6 | substance | Repr. 2; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H361d; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d; H302; H410 |
| fenpyrazamine (ISO); S-allyl 5-amino-2,3-dihydro-2-isopropyl-3-oxo-4- (o-tolyl)pyrazole-1-carbothioate; S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3- oxo-2,3-dihydropyrazole- 1-carbothioate | fenpyrazamine (ISO); S-allyl 5-amino-2,3-dihydro-2-isopropyl-3-oxo-4- (o-tolyl)pyrazole-1-carbothioate; S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3- oxo-2,3-dihydropyrazole- 1-carbothioate | 473798-59-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| imidazole | imidazole | 288-32-4 | 206-019-2 | substance | Repr. 1B; Acute Tox. 4; Skin Corr. 1C | Hazard statement codes: H360D; H302; H314. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H360D; H302; H314 | |
| lenacil (ISO); 3-cyclohexyl-6,7- dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione | lenacil (ISO); 3-cyclohexyl-6,7- dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione | 2164-08-1 | 218-499-0 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 |
| (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine | (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine | 86347-14-0 | substance | Acute Tox. 2; Acute Tox. 2; STOT SE 3; STOT SE 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 100 | Hazard statement codes: H330; H300; H336; H370 (eye); H372; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H300; H336; H370 (eye); H372; H410 | |
| triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4- chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol | triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4- chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol | 55219-65-3 | 259-537-6 | substance | Repr. 1B; Lact.; Acute Tox. 4; Aquatic Chronic 2 | Hazard statement codes: H360; H362; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360; H362; H302; H411 | |
| terbuthylazine (ISO); N-tert-butyl-6-chloro- N′-ethyl-1,3,5-triazine- 2,4-diamine | terbuthylazine (ISO); N-tert-butyl-6-chloro- N′-ethyl-1,3,5-triazine- 2,4-diamine | 5915-41-3 | 227-637-9 | substance | Acute Tox. 4; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H302; H373; H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H302; H373; H410 |
| quinolin-8-ol; 8-hydroxyquinoline | quinolin-8-ol; 8-hydroxyquinoline | 148-24-3 | 205-711-1 | substance | Repr. 1B; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H360D; H301; H318; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H360D; H301; H318; H317; H410 |
| thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2- ylidenecyanamide; {(2Z)-3-[(6-chloropyridin- 3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide | thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2- ylidenecyanamide; {(2Z)-3-[(6-chloropyridin- 3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide | 111988-49-9 | substance | Carc. 2; Repr. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H351; H360FD; H332; H301; H336; H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H351; H360FD; H332; H301; H336; H410 | |
| 2-methylisothiazol-3(2H)-one | 2-methylisothiazol-3(2H)-one | 2682-20-4 | 220-239-6 | substance | Acute Tox. 2; Acute Tox. 3; Acute Tox. 3; Skin Corr. 1B; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | Skin Sens. 1A; H317: | C ≥ 0.0015 % | M = 10 | M = 1 | Hazard statement codes: H330; H311; H301; H314; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS06; GHS09; Dgr. Labelling hazard statements: H330; H311; H301; H314; H317; H410. Supplementary hazard statements: EUH071 |
| pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2- methoxy-4-(trifluoromethyl) pyridine-3-sulfonamide | pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2- methoxy-4-(trifluoromethyl) pyridine-3-sulfonamide | 422556-08-9 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| 1-vinylimidazole | 1-vinylimidazole | 1072-63-5 | 214-012-0 | substance | Repr. 1B | Repr. 1B; H360D: | C ≥ 0.03 % | Hazard statement codes: H360D. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D |
| halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6- dimethoxypyrimidin-2-yl) carbamoyl]sulfamoyl}-1- methyl-1H-pyrazole-4- carboxylate | halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6- dimethoxypyrimidin-2-yl) carbamoyl]sulfamoyl}-1- methyl-1H-pyrazole-4- carboxylate | 100784-20-1 | substance | Repr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | M = 1000 | Hazard statement codes: H360D; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360D; H410 | |
| 2-methylimidazole | 2-methylimidazole | 693-98-1 | 211-765-7 | substance | Repr. 1B | Hazard statement codes: H360Df. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360Df | |
| (2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H- 1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole | (2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H- 1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole | 1417782- 03-6 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| oxathiapiprolin (ISO); 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3- yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5- methyl-3-(trifluoromethyl)-1H-pyrazol-1- yl]ethanone | oxathiapiprolin (ISO); 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3- yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5- methyl-3-(trifluoromethyl)-1H-pyrazol-1- yl]ethanone | 1003318- 67-9 | substance | Aquatic Chronic 1 | M = 1 | Hazard statement codes: H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| pyrithione zinc; (T-4)- bis[1-(hydroxy-.kappa.O)pyridine-2(1H)- thionato-.kappa.S]zinc | pyrithione zinc; (T-4)- bis[1-(hydroxy-.kappa.O)pyridine-2(1H)- thionato-.kappa.S]zinc | 13463- 41-7 | 236-671-3 | substance | Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 0.14 mg/L (dusts or mists) | oral: ATE = 221 mg/kg bw | M = 1000 | M = 10 | Hazard statement codes: H360D; H330; H301; H372; H318; H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H360D; H330; H301; H372; H318; H410 |
| flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one | flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one | 61213- 25-0 | 262-661-3 | substance | Repr. 1B; Acute Tox. 4; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 500 mg/kg bw | M = 100 | M = 100 | Hazard statement codes: H360FD; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360FD; H302; H317; H410 |
| 4,5-dichloro-2-octyl- 2H-isothiazol-3-one; [DCOIT] | 4,5-dichloro-2-octyl- 2H-isothiazol-3-one; [DCOIT] | 64359- 81-5 | 264-843-8 | substance | Acute Tox. 2; Acute Tox. 4; Skin Corr. 1; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 0.16 mg/L (dusts or mists) | oral: ATE = 567 mg/kg bw | Skin Irrit. 2; H315: 0.025 % ≤ C < 5 % | Eye Irrit. 2; H319: 0.025 % ≤ C < 3 % | Skin Sens. 1A; H317: C ≥ 0.0015 % | M = 100 | M = 100 | Hazard statement codes: H330; H302; H314; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H302; H314; H317; H410. Supplementary hazard statements: EUH071 |
| 2-methyl-1,2-benzothiazol-3(2H)-one; [MBIT] | 2-methyl-1,2-benzothiazol-3(2H)-one; [MBIT] | 2527-66-4 | substance | Acute Tox. 4; Acute Tox. 3; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 2 | dermal: ATE = 1100 mg/kg bw | oral: ATE = 175 mg/kg bw | Skin Sens. 1A; H317: C ≥ 0.0015 % | M = 1 | Hazard statement codes: H312; H301; H314; H318; H317; H400; H411. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H312; H301; H314; H317; H410. Supplementary hazard statements: EUH071 | |
| prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione | prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione | 178928-70-6 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| azamethiphos (ISO); S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate | azamethiphos (ISO); S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate | 35575-96-3 | 252-626-0 | substance | Acute Tox. 3; Acute Tox. 4; STOT SE 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 0.5 mg/L (dusts/mists) | Oral: ATE = 500 mg/kg bw | M = 1000 | M = 1000 | Hazard statement codes: H331; H302; H370 (nervous system); H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H302; H370 (nervous system); H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 3-methylpyrazole | 3-methylpyrazole | 1453-58-3 | 215-925-7 | substance | Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Corr. 1; Eye Dam. 1 | Oral: ATE = 500 mg/kg bw | Hazard statement codes: H360D; H302; H373 (lung); H314; H318. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H360D; H302; H373 (lung); H314. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one | clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one | 81777-89-1 | substance | Acute Tox. 4; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 4.85 mg/L (dusts/mists) | Oral: ATE = 768 mg/kg bw | M = 1 | M = 1 | Hazard statement codes: H332; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H302; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine | clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine | 74115-24-5 | 277-728-2 | substance | Aquatic Chronic 1 | M = 1 | Hazard statement codes: H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| theophylline; 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | theophylline; 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | 58-55-9 | 200-385-7 | substance | Repr. 1B | Hazard statement codes: H360D. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether | pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether | 179101-81-6 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | M = 100 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| Pyridine-2-thiol 1-oxide, sodium salt; pyrithione sodium; sodium pyrithione | Pyridine-2-thiol 1-oxide, sodium salt; pyrithione sodium; sodium pyrithione | 3811-73-2 15922-78-8 | 223-296-5 240-062-8 | substance | Acute Tox. 3; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 2 | Inhalation: ATE = 0.5mg/L (dusts/mists) | Dermal: ATE = 790 mg/kg bw | Oral: ATE = 500 mg/kg bw | M = 100 | Hazard statement codes: H331; H311; H302; H372 (nervous system); H315; H319; H317; H400; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H302; H372 (nervous system); H315; H319; H317; H410. Supplementary hazard statements: EUH070. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 1,3,5-triazine-2,4,6-triamine; melamine | 1,3,5-triazine-2,4,6-triamine; melamine | 108-78-1 | 203-615-4 | substance | Carc. 2; STOT RE 2 | Hazard statement codes: H351; H373 (urinary tract). Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351; H373 (urinary tract). Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| 4-nitrosomorpholine | 4-nitrosomorpholine | 59-89-2 | substance | Carc. 1B; Muta 2; STOT RE 1 | Carc. 1B; H350: C≥ 0.001% | Hazard statement codes: H350; H341; H372 (liver). Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H341; H372 (liver). Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 | |
| difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan_x0002_2-yl}methyl)-1H-1,2,4- triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4- chlorophenyl ether | difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan_x0002_2-yl}methyl)-1H-1,2,4- triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4- chlorophenyl ether | 119446-68-3 | substance | Acute Tox. 4; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 1450 mg/kg bw | M=10 | M=10 | Hazard statement codes: H302; H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H410. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 | |
| 9-[2-(ethoxycarbonyl) phenyl]–3,6-bis(ethylamino)–2,7- dimethylxanthylium chloride; Basic Red 1 | 9-[2-(ethoxycarbonyl) phenyl]–3,6-bis(ethylamino)–2,7- dimethylxanthylium chloride; Basic Red 1 | 989-38-8 | 213-584-9 | substance | Acute Tox. 3; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | oral ATE = 280 mg/kg bw | M = 10 | M = 1 | Hazard statement codes: H301; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS06; GHS09; Dgr. Labelling hazard statements: H301; H318; H317; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| 4-methylimidazole | 4-methylimidazole | 822-36-6 | 212-497-3 | substance | Carc. 1B; Repr. 1B | Hazard statement codes: H350; H360Fd. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H360Fd. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| 1H-benzotriazole | 1H-benzotriazole | 95-14-7 | 202-394-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H411. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| methyl-1H-benzotriazole | methyl-1H-benzotriazole | 29385-43-1 | 249-596-6 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H411. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| bixlozone (ISO); 2-(2,4-dichlorobenzyl)- 4,4-dimethyl-1,2-oxazo_x0002_lidin-3-one | bixlozone (ISO); 2-(2,4-dichlorobenzyl)- 4,4-dimethyl-1,2-oxazo_x0002_lidin-3-one | 81777-95-9 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H400; H410. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2- yl]pyridine | nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2- yl]pyridine | 54-11-5 | 200-193-3 | substance | Acute Tox. 2; Acute Tox. 2; Acute Tox. 2; Aquatic Chronic 2 | inhalation: | ATE = 0.19 mg/L | (dusts or mists) | dermal: | ATE = 70 mg/kg bw | oral: | ATE = 5 mg/kg bw | Hazard statement codes: H330; H310; H300; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H411 |
| salts of nicotine | salts of nicotine | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Aquatic Chronic 2 | Hazard statement codes: H330; H310; H300; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H411. Notes: A | |||
| strychnine | strychnine | 57-24-9 | 200-319-7 | substance | Acute Tox. 1; Acute Tox. 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H310; H300; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H310; H300; H410 | |
| salts of strychnine | salts of strychnine | substance | Acute Tox. 2 *; Acute Tox. 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H300; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H300; H410. Notes: A | |||
| colchicine | colchicine | 64-86-8 | 200-598-5 | substance | Muta. 1B; Acute Tox. 2 * | Hazard statement codes: H340; H300. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H340; H300 | |
| brucine; 2,3-dimethoxystrychnine | brucine; 2,3-dimethoxystrychnine | 357-57-3 | 206-614-7 | substance | Acute Tox. 2 *; Acute Tox. 2 *; Aquatic Chronic 3 | Hazard statement codes: H330; H300; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300; H412 | |
| brucine sulphate; [1] brucine nitrate; [2] strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3] strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] | brucine sulphate; [1] brucine nitrate; [2] strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3] strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] | 4845-99-2 [1] 5786-97-0 [2] 68239-26-9 [3] 68310-42-9 [4] | 225-432-9 [1] 227-317-9 [2] 269-439-5 [3] 269-710-8 [4] | substance | Acute Tox. 2 *; Acute Tox. 2 *; Aquatic Chronic 3 | Hazard statement codes: H330; H300; H412. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300; H412. Notes: A | |
| aconitine | aconitine | 302-27-2 | 206-121-7 | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300 | |
| salts of aconitine | salts of aconitine | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300. Notes: A | |||
| atropine | atropine | 51-55-8 | 200-104-8 | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300 | |
| salts of atropine | salts of atropine | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300. Notes: A | |||
| hyoscyamine | hyoscyamine | 101-31-5 | 202-933-0 | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300 | |
| salts of hyoscyamine | salts of hyoscyamine | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300. Notes: A | |||
| hyoscine | hyoscine | 51-34-3 | 200-090-3 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 * | Hazard statement codes: H330; H310; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H310; H300 | |
| salts of hyoscine | salts of hyoscine | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 * | Hazard statement codes: H330; H310; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H310; H300. Notes: A | |||
| pilocarpine | pilocarpine | 92-13-7 | 202-128-4 | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300 | |
| salts of pilocarpine | salts of pilocarpine | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300. Notes: A | |||
| papaverine | papaverine | 58-74-2 | 200-397-2 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| salts of papaverine | salts of papaverine | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302. Notes: A | |||
| physostigmine | physostigmine | 57-47-6 | 200-332-8 | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300 | |
| salts of physostigmine | salts of physostigmine | substance | Acute Tox. 2 *; Acute Tox. 2 * | Hazard statement codes: H330; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H300. Notes: A | |||
| digitoxin | digitoxin | 71-63-6 | 200-760-5 | substance | Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 * | Hazard statement codes: H331; H301; H373 **. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H301; H373 ** | |
| ephedrine | ephedrine | 299-42-3 | 206-080-5 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| salts of ephedrine | salts of ephedrine | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302. Notes: A | |||
| ouabain | ouabain | 630-60-4 | 211-139-3 | substance | Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 * | Hazard statement codes: H331; H301; H373 **. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H301; H373 ** | |
| strophantin-K | strophantin-K | 11005-63-3 | 234-239-9 | substance | Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 * | Hazard statement codes: H331; H301; H373 **. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H301; H373 ** | |
| bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-; red squill; scilliroside | bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-; red squill; scilliroside | 507-60-8 | 208-077-4 | substance | Acute Tox. 2 * | Hazard statement codes: H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H300 | |
| reaction mass of: 2-ethylhexyl mono-Dglucopyranoside; 2-ethylhexyl di-D-glucopyranoside | reaction mass of: 2-ethylhexyl mono-Dglucopyranoside; 2-ethylhexyl di-D-glucopyranoside | 414-420-0 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| constitutional isomers of penta-O-allyl-β-Dfructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-Dfructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-Dfructofuransoyl-α-D-glucopyranoside | constitutional isomers of penta-O-allyl-β-Dfructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-Dfructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-Dfructofuransoyl-α-D-glucopyranoside | 68784-14-5 | 419-640-0 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| emamectin benzoate (ISO); (4"R)-4"-deoxy-4"-(methylamino) avermectin B1 benzoate | emamectin benzoate (ISO); (4"R)-4"-deoxy-4"-(methylamino) avermectin B1 benzoate | 155569-91-8 | substance | Acute Tox. 3; Acute Tox. 3; Acute Tox. 3; STOT SE 1; STOT RE 1; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 0.663 mg/L (dusts/mists) | Dermal: ATE = 300 mg/kg bw | Oral: ATE = 60 mg/kg bw | STOT RE 1; H372: C ≥ 5 % | STOT RE 2; H373: 0.5 % ≤ C < 5 % | M = 10000 | M = 10000 | Hazard statement codes: H331; H311; H301; H370 (nervous system); H372 (nervous system); H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H370 (nervous system); H372 (nervous system); H318; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| methyl isocyanate | methyl isocyanate | 624-83-9 | 210-866-3 | substance | Flam. Liq. 2; Repr. 2; Acute Tox. 2 *; Acute Tox. 3 *; Acute Tox. 3 *; Resp. Sens. 1; Skin Sens. 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H225; H361d***; H330; H311; H301; H334; H317; H335; H315; H318. Labelling pictogram and signal word: GHS02; GHS06; GHS05; GHS08; Dgr. Labelling hazard statements: H225; H361d***; H330; H311; H301; H334; H317; H335; H315; H318 | |
| methyl isothiocyanate | methyl isothiocyanate | 556-61-6 | 209-132-5 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H301; H314; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H301; H314; H317; H410 | |
| thiocyanic acid | thiocyanic acid | 463-56-9 | 207-337-4 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H332; H312; H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302; H412. Supplementary hazard statements: EUH032 | |
| salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H332; H312; H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302; H412. Supplementary hazard statements: EUH032. Notes: A | |||
| 4,4’-methylenediphenyl diisocyanate; diphenylmethane-4,4’-diisocyanate; [1] 2,2’-methylenediphenyl diisocyanate; diphenylmethane-2,2’-diisocyanate; [2] o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4’-diisocyanate; [3] methylenediphenyl diisocyanate [4] | 4,4’-methylenediphenyl diisocyanate; diphenylmethane-4,4’-diisocyanate; [1] 2,2’-methylenediphenyl diisocyanate; diphenylmethane-2,2’-diisocyanate; [2] o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4’-diisocyanate; [3] methylenediphenyl diisocyanate [4] | 101-68-8 [1] 2536-05-2 [2] 5873-54-1 [3] 26447-40-5 [4] | 202-966-0 [1] 219-799-4 [2] 227-534-9 [3] 247-714-0 [4] | substance | Carc. 2; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 | Eye Irrit. 2; H319: C ≥ 5 % | Skin Irrit. 2; H315: C ≥ 5 % | Resp. Sens. 1; H334: C ≥ 0.1 % | STOT SE 3; H335: C ≥ 5 % | Hazard statement codes: H351; H332; H373**; H319; H335; H315; H334; H317. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H351; H332; H373**; H319; H335; H315; H334; H317. Notes: 2 C |
| 2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate; [1] 4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate; [2] m-tolylidene diisocyanate; toluene-diisocyanate [3] | 2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate; [1] 4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate; [2] m-tolylidene diisocyanate; toluene-diisocyanate [3] | 91-08-7 [1] 584-84-9 [2] 26471-62-5 [3] | 202-039-0 [1] 209-544-5 [2] 247-722-4 [3] | substance | Carc. 2; Acute Tox. 2 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 3 | Resp. Sens. 1; H334: C ≥ 0.1 % | Hazard statement codes: H351; H330; H319; H335; H315; H334; H317; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H351; H330; H319; H335; H315; H334; H317; H412. Notes: C |
| 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate | 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate | 4098-71-9 | 223-861-6 | substance | Acute Tox. 3 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 2 | * | Resp. Sens. 1; | H334: C ≥ 0.5 % | Skin Sens. 1; | H317: C ≥ 0.5 % | Hazard statement codes: H331; H319; H335; H315; H334; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H319; H335; H315; H334; H317; H411. Notes: 2 |
| 4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate | 4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate | 5124-30-1 | 225-863-2 | substance | Acute Tox. 3 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 | * | Resp. Sens. 1; | H334: C ≥ 0.5 % | Skin Sens. 1; | H317: C ≥ 0.5 % | Hazard statement codes: H331; H319; H335; H315; H334; H317. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H319; H335; H315; H334; H317. Notes: 2 |
| 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1] 2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] | 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1] 2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] | 16938-22-0 [1] 15646-96-5 [2] | 241-001-8 [1] 239-714-4 [2] | substance | Acute Tox. 3 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1 | * | Resp. Sens. 1; | H334: C ≥ 0.5 % | Skin Sens. 1; | H317: C ≥ 0.5 % | Hazard statement codes: H331; H319; H335; H315; H334. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H319; H335; H315; H334. Notes: 2 C |
| hexamethylene-di-isocyanate | hexamethylene-di-isocyanate | 822-06-0 | 212-485-8 | substance | Acute Tox. 3 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 | * | Resp. Sens. 1; | H334: C ≥ 0.5 % | Skin Sens. 1; | H317: C ≥ 0.5 % | Hazard statement codes: H331; H319; H335; H315; H334; H317. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H331; H319; H335; H315; H334; H317. Notes: 2 |
| 4-isocyanatosulphonyltoluene; tosyl isocyanate | 4-isocyanatosulphonyltoluene; tosyl isocyanate | 4083-64-1 | 223-810-8 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1 | Eye Irrit.; H319: | C ≥ 5 % | STOT SE 3; | H335: C ≥ 5 % | Skin Irrit. 2; | H315: C ≥ 5 % | Hazard statement codes: H319; H335; H315; H334. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H319; H335; H315; H334. Supplementary hazard statements: EUH014 |
| cyanamide; carbamonitril | cyanamide; carbamonitril | 420-04-2 | 206-992-3 | substance | Carc. 2; Repr. 2; Acute Tox. 3; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H351; H361fd; H311; H301; H373 (thyroid); H314; H317; H318; H412. Labelling pictogram and signal word: GHS08; GHS06; GHS05; Dgr. Labelling hazard statements: H351; H361fd; H311; H301; H373 (thyroid); H314; H317; H412 | |
| tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium) hexacyanoferrate | tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium) hexacyanoferrate | 7276-58-6 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | ||
| 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; isobornyl thiocyanoacetate | 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; isobornyl thiocyanoacetate | 115-31-1 | 204-081-5 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| potassium cyanate | potassium cyanate | 590-28-3 | 209-676-3 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| calcium cyanamide | calcium cyanamide | 156-62-7 | 205-861-8 | substance | Acute Tox. 4 *; STOT SE 3; Eye Dam. 1 | Hazard statement codes: H302; H335; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H335; H318 | |
| 2-(2-butoxyethoxy)ethyl thiocyanate | 2-(2-butoxyethoxy)ethyl thiocyanate | 112-56-1 | 203-985-7 | substance | Flam. Liq. 3; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H226; H311; H301. Labelling pictogram and signal word: GHS02; GHS06; Dgr. Labelling hazard statements: H226; H311; H301 | |
| dicyclohexylcarbodiimide | dicyclohexylcarbodiimide | 538-75-0 | 208-704-1 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H311; H302; H318; H317. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H311; H302; H318; H317 | |
| methylene dithiocyanate | methylene dithiocyanate | 6317-18-6 | 228-652-3 | substance | Acute Tox. 2 *; Acute Tox. 3 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H330; H301; H314; H317; H400. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H301; H314; H317; H400 | |
| 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; TGIC | 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; TGIC | 2451-62-9 | 219-514-3 | substance | Muta. 1B; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H340; H331; H301; H373 **; H318; H317; H412. Labelling pictogram and signal word: GHS06; GHS08; GHS05; Dgr. Labelling hazard statements: H340; H331; H301; H373 **; H318; H317; H412 | |
| methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate | methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate | 79277-18-2 | 410-550-7 | substance | STOT RE 2 *; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H373**; H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H373**; H334; H317. Supplementary hazard statements: EUH014 | |
| 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl) benzoate | 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl) benzoate | 83056-32-0 | 410-900-9 | substance | Flam. Liq. 3; Muta. 2; Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Resp. Sens. 1 | Hazard statement codes: H226; H341; H332; H373 **; H318; H334. Labelling pictogram and signal word: GHS02; GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H341; H332; H373 **; H318; H334. Supplementary hazard statements: EUH014 | |
| 2-phenylethylisocyanate | 2-phenylethylisocyanate | 1943-82-4 | 413-080-0 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H331; H302; H314; H334; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H302; H314; H334; H317; H411 | |
| 4,4'-ethylidenediphenyl dicyanate | 4,4'-ethylidenediphenyl dicyanate | 47073-92-7 | 405-740-1 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H302; H373 **; H318; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H332; H302; H373 **; H318; H410 | |
| 4,4'-methylenebis(2,6-dimethylphenyl cyanate) | 4,4'-methylenebis(2,6-dimethylphenyl cyanate) | 101657-77-6 | 405-790-4 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| ethyl 2-(isocyanatosulfonyl)benzoate | ethyl 2-(isocyanatosulfonyl)benzoate | 77375-79-2 | 410-220-2 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H302; H373**; H318; H334; H317. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H302; H373**; H318; H334; H317. Supplementary hazard statements: EUH014 | |
| 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane | 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane | 411-280-2 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H330; H302; H314; H334; H317; H412. Labelling pictogram and signal word: GHS06; GHS08; GHS05; Dgr. Labelling hazard statements: H330; H302; H314; H334; H317; H412 | ||
| alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H332; H312; H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302; H412. Notes: A | |||
| thallium thiocyanate | thallium thiocyanate | 3535-84-0 | 222-571-7 | substance | Acute Tox. 2 *; Acute Tox. 2 *; Acute Tox. 4 *; STOT RE 2; Aquatic Chronic 2 | Hazard statement codes: H330; H300; H312; H373**; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H300; H312; H373**; H411 | |
| metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H312; H302; H410. Notes: A | |||
| reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097) | reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097) | 430-980-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) | reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) | 430-750-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14) | reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14) | 122886-55-9 | 430-930-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) | 430-940-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1) | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1) | 430-950-5 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2) | reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2) | 430-960-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91) | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91) | 430-970-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 4-chlorophenylisocyanate | 4-chlorophenylisocyanate | 104-12-1 | 203-176-9 | substance | Acute Tox. 2 *; Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H302; H335; H315; H318; H334; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H302; H335; H315; H318; H334; H410 | |
| 4,4’-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | 4,4’-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | 420-530-1 | substance | Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H334; H317; H413. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317; H413 | ||
| 1,3-bis(1-isocyanato-1-methylethyl)benzene; [m-TMXDI] | 1,3-bis(1-isocyanato-1-methylethyl)benzene; [m-TMXDI] | 2778-42-9 | 220-474-4 | substance | Resp. Sens. 1; Skin Sens. 1A | Hazard statement codes: H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| Bis(isocyanatomethyl)benzene; [m-XDI] | Bis(isocyanatomethyl)benzene; [m-XDI] | 3634-83-1 | 222-852-4 | substance | Resp. Sens. 1; Skin Sens. 1A | Skin Sens. 1A; H317: C ≥ 0.001 % | Hazard statement codes: H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 2,4,6-triisopropyl-m-phenylene diisocyanate | 2,4,6-triisopropyl-m-phenylene diisocyanate | 2162-73-4 | 218-485-4 | substance | Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| 1,5-naphthylene diisocyanate [containing < 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] | 1,5-naphthylene diisocyanate [containing < 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] | 3173-72-6 | 221-641-4 | substance | STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Resp. Sens. 1; Skin Sens. 1A; Aquatic Chronic 3 | Hazard statement codes: H335; H315; H319; H334; H317; H412. Labelling pictogram and signal word: GHS07; GHS08; Dgr. Labelling hazard statements: H335; H315; H319; H334; H317; H412. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| 1,5-naphthylene diisocyanate [containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] | 1,5-naphthylene diisocyanate [containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] | 3173-72-6 | 221-641-4 | substance | Acute Tox. 2; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Resp. Sens. 1; Skin Sens. 1A; Aquatic Chronic 3 | Inhalation: | ATE = 0.27 mg/L (dusts/mists) | Hazard statement codes: H330; H335; H315; H319; H334; H317; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H330; H335; H315; H319; H334; H317; H412. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 3,3'-dimethylbiphenyl_x0002_4,4'-diyl diisocyanate | 3,3'-dimethylbiphenyl_x0002_4,4'-diyl diisocyanate | 91-97-4 | 202-112-7 | substance | Carc. 2; Resp. Sens. 1; Skin Sens. 1A | Skin Sens.1A; H317: C ≥0.001% | Hazard statement codes: H351; H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H351; H334; H317. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| N,N-dimethylformamide; dimethyl formamide | N,N-dimethylformamide; dimethyl formamide | 68-12-2 | 200-679-5 | substance | Repr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H360D ***; H332; H312; H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360D ***; H332; H312; H319 | |
| 2-fluoroacetamide | 2-fluoroacetamide | 640-19-7 | 211-363-1 | substance | Acute Tox. 2 *; Acute Tox. 3 * | Hazard statement codes: H300; H311. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H300; H311 | |
| acrylamide; prop-2-enamide | acrylamide; prop-2-enamide | 79-06-1 | 201-173-7 | substance | Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 3 *; STOT RE 1; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H350; H340; H361f ***; H301; H372 **; H332; H312; H319; H315; H317. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H350; H340; H361f ***; H301; H372 **; H332; H312; H319; H315; H317. Notes: D | |
| allidochlor (ISO); N,N-diallylchloroacetamide | allidochlor (ISO); N,N-diallylchloroacetamide | 93-71-0 | 202-270-7 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H319; H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H319; H315; H411 | |
| chlorthiamid (ISO); 2,6-dichloro (thiobenzamide) | chlorthiamid (ISO); 2,6-dichloro (thiobenzamide) | 1918-13-4 | 217-637-7 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| dichlofluanid (ISO); N-[(dichlorofluoromethyl) thio]-N′,N′-dimethyl-N- phenylsulfamide | dichlofluanid (ISO); N-[(dichlorofluoromethyl) thio]-N′,N′-dimethyl-N- phenylsulfamide | 1085-98-9 | 214-118-7 | substance | Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1 | M = 10 | Hazard statement codes: H332; H319; H317; H400. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H319; H317; H400 |
| diphenamid (ISO); N,N-dimethyl-2,2-diphenylacetamide | diphenamid (ISO); N,N-dimethyl-2,2-diphenylacetamide | 957-51-7 | 213-482-4 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| propachlor (ISO); 2-chloro-N-isopropylacetanilide; α-chloro-N-isopropylacetanilide | propachlor (ISO); 2-chloro-N-isopropylacetanilide; α-chloro-N-isopropylacetanilide | 1918-16-7 | 217-638-2 | substance | Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H317; H410 | |
| propanil (ISO); 3’, 4’-dichloropropionanilide | propanil (ISO); 3’, 4’-dichloropropionanilide | 709-98-8 | 211-914-6 | substance | Acute Tox. 4 *; Aquatic Acute 1 | M=10 | Hazard statement codes: H302; H400. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H400 |
| tosylchloramide sodium | tosylchloramide sodium | 127-65-1 | 204-854-7 | substance | Acute Tox. 4 *; Skin Corr. 1B; Resp. Sens. 1 | Hazard statement codes: H302; H314; H334. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dg. Labelling hazard statements: H302; H314; H334. Supplementary hazard statements: EUH031 | |
| N,N-dimethylacetamide | N,N-dimethylacetamide | 127-19-5 | 204-826-4 | substance | Repr. 1B; Acute Tox. 4*; Acute Tox. 4* | Hazard statement codes: H360D***; H332; H312. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360D***; H332; H312’ | |
| N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide | N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide | 719-96-0 | 211-952-3 | substance | Skin Irrit. 2 | Hazard statement codes: H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315 | |
| butyraldehyde oxime | butyraldehyde oxime | 110-69-0 | 203-792-8 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H311; H302; H319. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H311; H302; H319 | |
| butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime | butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime | 96-29-7 | 202-496-6 | substance | Carc. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3; STOT SE 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | dermal: ATE = 1100 mg/kg bw | oral: ATE = 100 mg/kg bw | Hazard statement codes: H350; H312; H301; H336; H370 (upper respiratory tract); H373 (blood system); H315; H318; H317. Labelling pictogram and signal word: GHS08; GHS06; GHS05; Dgr. Labelling hazard statements: H350; H312; H301; H336; H370 (upper respiratory tract); H373 (blood system); H315; H318; H317 |
| alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl) acetanilide | alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl) acetanilide | 15972-60-8 | 240-110-8 | substance | Carc. 2; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H351; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H317; H410 |
| 1-(3,4-dichlorophenylimino) thiosemicarbazide | 1-(3,4-dichlorophenylimino) thiosemicarbazide | 5836-73-7 | substance | Acute Tox. 2 * | Hazard statement codes: H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H300 | ||
| cartap hydrochloride | cartap hydrochloride | 15263-52-2 | 239-309-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H410 | |
| diethyltoluamide (ISO): N, N-diethyl-m-toluamide; [deet] | diethyltoluamide (ISO): N, N-diethyl-m-toluamide; [deet] | 134-62-3 | 205-149-7 | substance | Acute Tox. 4; Skin Irrit. 2; Eye Irrit. 2 | oral: ATE = 1892 mg/kg bw | Hazard statement codes: H302; H315; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H315; H319 |
| perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; | perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; | 37924-13-3 | 253-718-3 | substance | Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319 | |
| tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)- 1,3-dimethylurea | tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)- 1,3-dimethylurea | 34014-18-1 | 251-793-7 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| thiazafluron (ISO); 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4- thiadiazol-2-yl)urea | thiazafluron (ISO); 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4- thiadiazol-2-yl)urea | 25366-23-8 | 246-901-4 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| acetamide | acetamide | 60-35-5 | 200-473-5 | substance | Carc. 2 | Hazard statement codes: H351. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351 | |
| N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide | N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide | 401-980-6 | substance | Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H317 | ||
| 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy) butyramido)-4,4-dimethyl-3-oxovaleranilide | 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy) butyramido)-4,4-dimethyl-3-oxovaleranilide | 54942-74-4 | 402-260-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| valinamide | valinamide | 20108-78-5 | 402-840-7 | substance | Repr. 2; Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H361f ***; H319; H317. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361f ***; H319; H317 | |
| thioacetamide | thioacetamide | 62-55-5 | 200-541-4 | substance | Carc. 1B; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H350; H302; H319; H315; H412. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302; H319; H315; H412 | |
| tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate | tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate | 403-760-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide | N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide | 108673-51-4 | 403-790-9 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| N,N'-ethylenebis(vinylsulfonylacetamide) | N,N'-ethylenebis(vinylsulfonylacetamide) | 66710-66-5 | 404-790-1 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| ethidimuron (ISO); 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea | ethidimuron (ISO); 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea | 30043-49-3 | 250-010-6 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| dimethachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; | dimethachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; | 50563-36-5 | 256-625-6 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide; 2′,4′-difluoro-2-(α,α,α- trifluoro-m-tolyloxy) nicotinanilide | diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide; 2′,4′-difluoro-2-(α,α,α- trifluoro-m-tolyloxy) nicotinanilide | 83164-33-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 10000 | M = 1000 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide | cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide | 69581-33-5 | 274-050-9 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H312; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H312; H410 | |
| pyracarbolid; (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide | pyracarbolid; (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide | 24691-76-7 | 246-419-4 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide;[1] (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide;[2] | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide;[1] (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide;[2] | 57966-95-7 [1] 166900-80-7 [2] | 261-043-0 [1] -[2] | substance | Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 360 mg/kg bw | M = 1 | M = 1 | Hazard statement codes: H361fd; H302; H373 (blood, thymus, eyes); H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361fd; H302; H373 (blood, thymus, eyes); H317; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| 2-chloracetamide | 2-chloracetamide | 79-07-2 | 201-174-2 | substance | Repr. 2; Acute Tox. 3 *; Skin Sens. 1 | Skin Sens. 1; | H317: C ≥ 0.1 % | Hazard statement codes: H361f ***; H301; H317. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H361f ***; H301; H317 |
| acetochlor (ISO); 2- chloro-N-(ethoxymethyl)-N-(2-ethyl-6- methylphenyl)acetamide | acetochlor (ISO); 2- chloro-N-(ethoxymethyl)-N-(2-ethyl-6- methylphenyl)acetamide | 34256-82-1 | 251-899-3 | substance | Carc. 2; Repr. 2; Acute Tox. 4; STOT SE 3; STOT RE 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | M = 100 | Hazard statement codes: H351; H361f; H332; H335; H373 (kidney); H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H361f; H332; H335; H373 (kidney); H315; H317; H410 |
| (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride | (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride | 88918-84-7 | 406-010-5 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | |
| 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide | 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide | 117827-06-2 | 406-200-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide | potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide | 97888-41-0 | 406-650-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide | 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide | 101664-25-9 | 406-840-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide | N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide | 142859-67-4 | 407-070-5 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide | isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide | 82558-50-7 | 407-190-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide | N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide | 402-510-2 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide | 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide | 122371-93-1 | 405-190-2 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy) octanamide | N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy) octanamide | 406-390-2 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide | reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide | 406-640-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 3'-trifluoromethylisobutyranilide | 3'-trifluoromethylisobutyranilide | 1939-27-1 | 406-740-4 | substance | STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H373 **; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H411 | |
| 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide | 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide | 99141-89-6 | 408-150-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide | lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide | 103055-07-8 | 410-690-9 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene | reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene | 411-070-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| formamide | formamide | 75-12-7 | 200-842-0 | substance | Repr. 1B | Hazard statement codes: H360D ***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D *** | |
| N-methylacetamide | N-methylacetamide | 79-16-3 | 201-182-6 | substance | Repr. 1B | Hazard statement codes: H360D ***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D *** | |
| iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide | iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide | 36734-19-7 | 253-178-9 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide | propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide | 23950-58-5 | 245-951-4 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| N-methylformamide | N-methylformamide | 123-39-7 | 204-624-6 | substance | Repr. 1B; Acute Tox. 4 * | Hazard statement codes: H360D ***; H312. Labelling pictogram and signal word: GHS08; GHS07; Dg. Labelling hazard statements: H360D ***; H312 | |
| reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy) propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide | reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy) propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide | 412-790-8 | substance | Carc. 1B; Muta. 2; STOT RE 2 * | Hazard statement codes: H350; H341; H373 **. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350; H341; H373 ** | ||
| 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl) benzene | 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl) benzene | 119462-56-5 | 412-570-1 | substance | STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H318; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H373 **; H318; H317; H410 | |
| 4-((4-(diethylamino)-2-ethoxyphenyl) imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide | 4-((4-(diethylamino)-2-ethoxyphenyl) imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide | 121487-83-0 | 412-650-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) | Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) | 413-770-1 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H314; H317; H410 | ||
| N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide | N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide | 124172-53-8 | 413-610-0 | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | |
| N-[3-[(2-acetyloxy)ethyl](phenyl-methyl) amino]-4-methoxyphenylacetamide | N-[3-[(2-acetyloxy)ethyl](phenyl-methyl) amino]-4-methoxyphenylacetamide | 70693-57-1 | 411-590-8 | substance | Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H314; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314; H412 | |
| 3-dodecyl-(1-(1,2,2,6,6-pentamethyl- 4-piperidin)-yl)-2,5-pyrrolidindione | 3-dodecyl-(1-(1,2,2,6,6-pentamethyl- 4-piperidin)-yl)-2,5-pyrrolidindione | 106917-30-0 | 411-920-0 | substance | Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1A; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H302; H373 **; H314; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H302; H373 **; H314; H410 | |
| N—tert-butyl-3-methylpicolinamide | N—tert-butyl-3-methylpicolinamide | 32998-95-1 | 406-720-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea | 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea | 79881-89-3 | 411-970-3 | substance | Acute Tox. 4 *; STOT RE 2 * | Hazard statement codes: H302; H373 **. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373 ** | |
| 5,6,12,13-tetrachloroanthra(2,1,9- def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone | 5,6,12,13-tetrachloroanthra(2,1,9- def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone | 115662-06-1 | 405-100-1 | substance | Repr. 2 | Hazard statement codes: H361f ***. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361f *** | |
| dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate | 92683-20-0 | 407-300-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| potassium 4-(11-methacrylamidoundecanamido) benzenesulfonate | potassium 4-(11-methacrylamidoundecanamido) benzenesulfonate | 174393-75-0 | 406-500-9 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide | 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide | 110560-22-0 | 406-210-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea | reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea | 406-530-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; bis(N-octadecyl-N'-phenyleneureido)methylene; bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) | reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; bis(N-octadecyl-N'-phenyleneureido)methylene; bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) | 406-550-1 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine | 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine | 55612-11-8 | 407-120-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 4'-ethoxy-2-benzimidazoleanilide | 4'-ethoxy-2-benzimidazoleanilide | 120187-29-3 | 407-600-5 | substance | Muta. 2; Aquatic Chronic 4 | Hazard statement codes: H341; H413. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H341; H413 | |
| N-butyl-2-(4-morpholinylcarbonyl)benzamide | N-butyl-2-(4-morpholinylcarbonyl)benzamide | 104958-67-0 | 407-730-2 | substance | Eye Irrit. 2; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H319; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317; H412 | |
| D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) | D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) | 65197-96-8 | 408-120-9 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | |
| tebufenozide (ISO); N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide | tebufenozide (ISO); N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide | 112410-23-8 | 412-850-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra [2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate | reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra [2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate | 411-310-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide | 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide | 104541-33-5 | 411-330-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate | 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate | 140921-24-0 | 411-700-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 |
Official source
Entries are copied exactly as published. Not legal advice; always check the official text.